[go: up one dir, main page]

DE69404116D1 - Mit Zucker überzogene pharmazeutische Dosierungseinheit - Google Patents

Mit Zucker überzogene pharmazeutische Dosierungseinheit

Info

Publication number
DE69404116D1
DE69404116D1 DE69404116T DE69404116T DE69404116D1 DE 69404116 D1 DE69404116 D1 DE 69404116D1 DE 69404116 T DE69404116 T DE 69404116T DE 69404116 T DE69404116 T DE 69404116T DE 69404116 D1 DE69404116 D1 DE 69404116D1
Authority
DE
Germany
Prior art keywords
sugar
dosage unit
pharmaceutical dosage
unit coated
coated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69404116T
Other languages
English (en)
Other versions
DE69404116T2 (de
Inventor
Haan Pieter De
Marcus Johannes Maria Deurloo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of DE69404116D1 publication Critical patent/DE69404116D1/de
Application granted granted Critical
Publication of DE69404116T2 publication Critical patent/DE69404116T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DE69404116T 1993-12-23 1994-12-22 Mit Zucker überzogene pharmazeutische Dosierungseinheit Expired - Fee Related DE69404116T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93203645 1993-12-23

Publications (2)

Publication Number Publication Date
DE69404116D1 true DE69404116D1 (de) 1997-08-14
DE69404116T2 DE69404116T2 (de) 1997-11-13

Family

ID=8214236

Family Applications (2)

Application Number Title Priority Date Filing Date
DE0659432T Pending DE659432T1 (de) 1993-12-23 1994-12-22 Mit Zucket überzogene pharmazeutische Dosierungseinheit.
DE69404116T Expired - Fee Related DE69404116T2 (de) 1993-12-23 1994-12-22 Mit Zucker überzogene pharmazeutische Dosierungseinheit

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE0659432T Pending DE659432T1 (de) 1993-12-23 1994-12-22 Mit Zucket überzogene pharmazeutische Dosierungseinheit.

Country Status (16)

Country Link
US (1) US5662936A (de)
EP (1) EP0659432B1 (de)
JP (1) JPH07206681A (de)
KR (1) KR100330560B1 (de)
CN (1) CN1108929A (de)
AT (1) ATE155039T1 (de)
AU (1) AU685538B2 (de)
CA (1) CA2138451C (de)
DE (2) DE659432T1 (de)
DK (1) DK0659432T3 (de)
ES (1) ES2105501T3 (de)
FI (1) FI116035B (de)
GR (1) GR3024817T3 (de)
NO (1) NO305273B1 (de)
NZ (1) NZ270228A (de)
ZA (1) ZA949929B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
CA2205897A1 (en) * 1994-11-22 1996-05-30 Malcolm Cecil Pike Compositions and methods for contraception and for treatment of benign gynecological disorders
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
ATE195871T1 (de) * 1997-09-23 2000-09-15 Akzo Nobel Nv Steroid enthaltende dosierungsformen mit einer steroiddichten umhüllung
WO2000074754A2 (en) 1999-06-05 2000-12-14 Innovata Biomed Limited Delivery system
GB9920839D0 (en) 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
CZ20021198A3 (cs) * 1999-10-11 2002-09-11 Ml Laboratories Plc Zařízení pro podávání léčiva s povrchovou úpravou odolnou proti vlhkosti
US6254888B1 (en) 2000-01-28 2001-07-03 Boehringer Ingelheim Pharmaceuticals, Inc. Method for coating pharmaceutical dosage forms
EP1269995A1 (de) * 2000-03-27 2003-01-02 Kyowa Hakko Kogyo Co., Ltd. Einfach einnehmbares granulat
CA2408956C (en) * 2000-05-18 2011-07-12 Therics, Inc. Method and form of a drug delivery device,such as encapsulating a toxic core within a non-toxic region in an oral dosage form
JP2002068965A (ja) * 2000-08-31 2002-03-08 Teikoku Hormone Mfg Co Ltd 単層糖衣錠及びその製造方法
WO2002036077A2 (en) * 2000-11-06 2002-05-10 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US7303763B2 (en) * 2001-02-12 2007-12-04 Watson Laboratories, Inc. Compositions for conjugated estrogens and associated methods
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
EP1744800B1 (de) 2004-04-21 2016-06-22 Innovata Biomed Limited Inhalator
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
ATE478564T1 (de) * 2004-10-15 2010-09-15 Suedzucker Ag Verbessertes trommelcoating-verfahren
JP4808453B2 (ja) * 2005-08-26 2011-11-02 株式会社荏原製作所 研磨方法及び研磨装置
WO2007035961A2 (en) * 2005-09-23 2007-03-29 Threshold Pharmaceuticals, Inc. Anti-cancer therapies
CN103281913A (zh) * 2010-12-29 2013-09-04 雀巢产品技术援助有限公司 包含团聚的油粉的糖果产品
IN2014DN10980A (de) * 2012-07-03 2015-09-18 Nestec Sa
JP2016501854A (ja) * 2012-11-22 2016-01-21 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツングＥｖｏｎｉｋ Ｒｏｅｈｍ ＧｍｂＨ 粉末組成物から顆粒状産物を製造する方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2736682A (en) * 1954-10-11 1956-02-28 Victor M Hermelin Method of making a prolonged action medicinal tablet
US3576663A (en) * 1967-05-29 1971-04-27 Colorcon Coated tablet
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations

Also Published As

Publication number Publication date
FI946043A0 (fi) 1994-12-22
AU8168494A (en) 1995-06-29
US5662936A (en) 1997-09-02
CN1108929A (zh) 1995-09-27
FI116035B (fi) 2005-09-15
EP0659432A1 (de) 1995-06-28
CA2138451A1 (en) 1995-06-24
KR100330560B1 (ko) 2002-09-05
NZ270228A (en) 1995-09-26
AU685538B2 (en) 1998-01-22
FI946043L (fi) 1995-06-24
NO944991D0 (no) 1994-12-22
DE69404116T2 (de) 1997-11-13
JPH07206681A (ja) 1995-08-08
ES2105501T3 (es) 1997-10-16
NO305273B1 (no) 1999-05-03
CA2138451C (en) 2007-04-24
ZA949929B (en) 1995-08-23
NO944991L (no) 1995-06-26
KR950016715A (ko) 1995-07-20
GR3024817T3 (en) 1998-01-30
DE659432T1 (de) 1997-01-30
DK0659432T3 (da) 1998-02-16
ATE155039T1 (de) 1997-07-15
EP0659432B1 (de) 1997-07-09

Similar Documents

Publication Publication Date Title
DE69404116D1 (de) Mit Zucker überzogene pharmazeutische Dosierungseinheit
NO20003546L (no) Anvendelse av progestin og en farmasøytisk sammensetning samt et kit inneholdende disse
DK0402950T3 (da) Behandling af postmenopausale ulemper
ID28003A (id) Turunan-turunan adamantana
NO995245L (no) Anvendelse av tetrahydropyridinderivater for fremstilling av medisiner for å behandle sykdommer som bevirker demyelinisering
MX9203417A (es) Compuestos de diarilo antiateroescleroticos.
GR1000723B (el) Aντιστροφος ατροφια του δερματος η οποια προκαλειται απο γλυκοκορτικοειδη
GB9414966D0 (en) Pharmaceutical compositions for the nasal administration of antiviral agents
ITRM910002A1 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
DE3686022D1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
ATE97001T1 (de) Topisch anzuwendende defibrotid enthaltende arzneizubereitungen.
NO940777L (no) Anvendelse av et pregnanderivat
NZ332655A (en) Pharmaceutical compositions containing diclofenac and alkali metal bicarbonates
NO934832D0 (no) Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose
ITMI913510A1 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
ATE169922T1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase
AU8186291A (en) A controlled-release pharmaceutical composition for the oral use containing non steroidal anti-inflammatory drugs
IT9021021A0 (it) Composizioni farmaceutiche per la somministrazione orale di irudina
DK115789A (da) Farmaceutisk middel til oral indtagelse, isaer til jern- og magnesiumsubstitutionstetapi
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
LV10917A (lv) Bambuterina pielietojums lipidu saturu pazeminosu farmaceitisku kompoziciju pagatavosanai
ITMI911445A1 (it) Impiego di derivati fosfolipidici per la preparazione di composizioni farmaceutiche aventi attivita' immunosoppressiva
FR2685204B1 (fr) Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine.
HUP9801985A3 (en) Use of cystine derivatives for the preparation of pharmaceutical compositions useful for the treatment of restenosis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: N.V. ORGANON, OSS, NL

8339 Ceased/non-payment of the annual fee